Discovering functional evolutionary dependencies in human cancers
- 28 September 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 52 (11), 1198-1207
- https://doi.org/10.1038/s41588-020-0703-5
Abstract
Cancer cells retain genomic alterations that provide a selective advantage. The prediction and validation of advantageous alterations are major challenges in cancer genomics. Moreover, it is crucial to understand how the coexistence of specific alterations alters response to genetic and therapeutic perturbations. In the present study, we inferred functional alterations and preferentially selected combinations of events in >9,000 human tumors. Using a Bayesian inference framework, we validated computational predictions with high-throughput readouts from genetic and pharmacological screenings on 2,000 cancer cell lines. Mutually exclusive and co-occurring cancer alterations reflected, respectively, functional redundancies able to rescue the phenotype of individual target inhibition, or synergistic interactions, increasing oncogene addiction. Among the top scoring dependencies, co-alteration of the phosphoinositide 3-kinase (PI3K) subunit PIK3CA and the nuclear factor NFE2L2 was a synergistic evolutionary trajectory in squamous cell carcinomas. By integrating computational, experimental and clinical evidence, we provide a framework to study the combinatorial functional effects of cancer genomic alterations.Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_169519)
This publication has 58 references indexed in Scilit:
- Mutual exclusivity analysis identifies oncogenic network modulesGenome Research, 2011
- Cells of origin in cancerNature, 2011
- The landscape of somatic copy-number alteration across human cancersNature, 2010
- Patient-oriented gene set analysis for cancer mutation dataGenome Biology, 2010
- A human B‐cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centersMolecular Systems Biology, 2010
- Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer CellsCell, 2009
- Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancerGenes & Development, 2006
- Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K- ras oncogene in vivoProceedings of the National Academy of Sciences of the United States of America, 2006
- Tissue, cell and stage specificity of (epi)mutations in cancersNature Reviews Cancer, 2005
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategyNature, 2005